CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-28 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 142,157 | ||
| 2026-10-27 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-27 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −3,000 | $26.58 | $80K | 386,683 |
| 2026-10-27 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −8,881 | $27.53 | $244K | 377,802 |
| 2026-10-27 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 154,038 | ||
| 2026-10-26 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-26 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −8,503 | $25.94 | $221K | 381,180 |
| 2026-10-26 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −3,378 | $26.30 | $89K | 377,802 |
| 2026-10-26 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 165,919 | ||
| 2026-10-23 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-23 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −4,500 | $24.50 | $110K | 385,183 |
| 2026-10-23 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −7,381 | $25.28 | $187K | 377,802 |
| 2026-10-23 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 177,800 | ||
| 2026-10-22 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-22 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −10,181 | $24.38 | $248K | 379,502 |
| 2026-10-22 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −1,700 | $25.29 | $43K | 377,802 |
| 2026-10-22 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 189,681 | ||
| 2026-10-21 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-21 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −5,999 | $25.25 | $151K | 383,684 |
| 2026-10-21 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −5,882 | $25.57 | $150K | 377,802 |
Page 3 of 119 · 2,375 trades